Dianthus Therapeutics, Inc. /DE/ (DNTH) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
19/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinDNTH / S&P 16.16% / 15.20% |
LoseDNTH / S&P DNTH unavailable / 15.00% |
LoseDNTH / S&P 30.06% / 50.40% |
| 2026-Q12/3 |
WinDNTH / S&P 103.64% / -4.33% |
LoseDNTH / S&P DNTH unavailable / 11.30% |
WinDNTH / S&P 46.02% / 27.70% |
| 2025-Q42/3 |
WinDNTH / S&P 4.73% / 2.65% |
LoseDNTH / S&P -67.35% / 9.00% |
WinDNTH / S&P 60.54% / 13.40% |
| 2025-Q31/3 |
WinDNTH / S&P 111.22% / 8.12% |
LoseDNTH / S&P -42.64% / 4.61% |
LoseDNTH / S&P -148.74% / 13.45% |
| 2025-Q21/3 |
LoseDNTH / S&P 2.70% / 10.94% |
WinDNTH / S&P 17.87% / 4.83% |
LoseDNTH / S&P -179.13% / 10.63% |
| 2025-Q10/3 |
LoseDNTH / S&P -16.79% / -4.27% |
LoseDNTH / S&P DNTH unavailable / 4.98% |
LoseDNTH / S&P -64.32% / 10.57% |
| 2024-Q40/3 |
LoseDNTH / S&P -20.38% / 2.41% |
LoseDNTH / S&P DNTH unavailable / 5.25% |
LoseDNTH / S&P -83.33% / 6.15% |
| 2024-Q30/3 |
LoseDNTH / S&P 5.80% / 5.89% |
LoseDNTH / S&P DNTH unavailable / 5.89% |
LoseDNTH / S&P -119.79% / 6.11% |
| 2024-Q20/3 |
LoseDNTH / S&P -13.73% / 4.28% |
LoseDNTH / S&P DNTH unavailable / 5.38% |
LoseDNTH / S&P -109.98% / 5.12% |
| 2024-Q11/3 |
WinDNTH / S&P 188.46% / 10.56% |
LoseDNTH / S&P DNTH unavailable / 5.71% |
LoseDNTH / S&P -71.93% / 5.59% |
| 2023-Q40/3 |
LoseDNTH / S&P -23.92% / 11.69% |
LoseDNTH / S&P DNTH unavailable / 6.81% |
LoseDNTH / S&P -25.96% / 7.78% |
| 2023-Q32/3 |
WinDNTH / S&P 12.42% / -3.27% |
LoseDNTH / S&P DNTH unavailable / 7.52% |
WinDNTH / S&P 265.45% / -5.03% |
| 2023-Q21/3 |
LoseDNTH / S&P -3.80% / 8.74% |
LoseDNTH / S&P DNTH unavailable / 9.50% |
WinDNTH / S&P 3076.92% / -8.57% |
| 2023-Q12/3 |
WinDNTH / S&P 97.50% / 7.50% |
LoseDNTH / S&P DNTH unavailable / 10.77% |
WinDNTH / S&P 2069.92% / -15.69% |
| 2022-Q41/3 |
LoseDNTH / S&P -71.63% / 7.56% |
LoseDNTH / S&P DNTH unavailable / 11.88% |
WinDNTH / S&P 1526.92% / -17.99% |
| 2022-Q31/3 |
WinDNTH / S&P 17.50% / -4.88% |
LoseDNTH / S&P DNTH unavailable / 13.47% |
LoseDNTH / S&P DNTH unavailable / -1.41% |
| 2022-Q20/3 |
LoseDNTH / S&P -58.62% / -16.10% |
LoseDNTH / S&P DNTH unavailable / 13.71% |
LoseDNTH / S&P DNTH unavailable / 11.04% |
| 2022-Q10/3 |
LoseDNTH / S&P -34.54% / -4.60% |
LoseDNTH / S&P DNTH unavailable / 15.97% |
LoseDNTH / S&P DNTH unavailable / 42.23% |
| 2021-Q40/3 |
LoseDNTH / S&P -39.15% / 11.03% |
LoseDNTH / S&P DNTH unavailable / 15.00% |
LoseDNTH / S&P DNTH unavailable / 96.40% |
| 2021-Q30/3 |
LoseDNTH / S&P -25.56% / 0.58% |
LoseDNTH / S&P DNTH unavailable / 10.77% |
LoseDNTH / S&P DNTH unavailable / 69.42% |
| 2021-Q20/3 |
LoseDNTH / S&P -17.40% / 8.55% |
LoseDNTH / S&P DNTH unavailable / 6.58% |
LoseDNTH / S&P DNTH unavailable / 51.81% |
| 2021-Q11/3 |
WinDNTH / S&P 51.02% / 6.17% |
LoseDNTH / S&P DNTH unavailable / -1.06% |
LoseDNTH / S&P DNTH unavailable / 7.39% |
| 2020-Q41/3 |
WinDNTH / S&P 15.29% / 12.15% |
LoseDNTH / S&P DNTH unavailable / -3.72% |
LoseDNTH / S&P DNTH unavailable / -33.42% |
| 2020-Q30/3 |
LoseDNTH / S&P -9.45% / 8.93% |
LoseDNTH / S&P DNTH unavailable / -2.04% |
LoseDNTH / S&P DNTH unavailable / -27.10% |
| 2020-Q20/3 |
LoseDNTH / S&P 19.59% / 20.54% |
LoseDNTH / S&P DNTH unavailable / -0.46% |
LoseDNTH / S&P DNTH unavailable / -27.11% |
| 2020-Q10/3 |
LoseDNTH / S&P -58.58% / -19.60% |
LoseDNTH / S&P DNTH unavailable / 3.47% |
LoseDNTH / S&P DNTH unavailable / -14.75% |
| 2019-Q41/3 |
WinDNTH / S&P 47.76% / 9.07% |
LoseDNTH / S&P DNTH unavailable / 5.36% |
LoseDNTH / S&P DNTH unavailable / 2.99% |
| 2019-Q30/3 |
LoseDNTH / S&P -30.44% / 1.70% |
LoseDNTH / S&P DNTH unavailable / 5.02% |
LoseDNTH / S&P DNTH unavailable / 0.21% |
| 2019-Q20/3 |
LoseDNTH / S&P -10.44% / 4.30% |
LoseDNTH / S&P DNTH unavailable / 6.64% |
LoseDNTH / S&P DNTH unavailable / 8.65% |
| 2019-Q11/3 |
WinDNTH / S&P 188.95% / 13.65% |
LoseDNTH / S&P DNTH unavailable / 8.12% |
LoseDNTH / S&P DNTH unavailable / 14.29% |
| 2018-Q40/3 |
LoseDNTH / S&P -52.54% / -13.52% |
LoseDNTH / S&P DNTH unavailable / 9.05% |
LoseDNTH / S&P DNTH unavailable / 18.23% |
| 2018-Q30/3 |
LoseDNTH / S&P -11.04% / 7.71% |
LoseDNTH / S&P DNTH unavailable / 10.21% |
LoseDNTH / S&P DNTH unavailable / 19.06% |
| 2018-Q20/3 |
LoseDNTH / S&P DNTH unavailable / 3.43% |
LoseDNTH / S&P DNTH unavailable / 9.03% |
LoseDNTH / S&P DNTH unavailable / 14.46% |
| 2018-Q10/3 |
LoseDNTH / S&P DNTH unavailable / -0.76% |
LoseDNTH / S&P DNTH unavailable / 7.68% |
LoseDNTH / S&P DNTH unavailable / 12.46% |
| 2017-Q40/3 |
LoseDNTH / S&P DNTH unavailable / 6.64% |
LoseDNTH / S&P DNTH unavailable / 7.03% |
LoseDNTH / S&P DNTH unavailable / 13.82% |
| 2017-Q30/3 |
LoseDNTH / S&P DNTH unavailable / 4.48% |
LoseDNTH / S&P DNTH unavailable / 5.68% |
LoseDNTH / S&P DNTH unavailable / 17.57% |
| 2017-Q20/3 |
LoseDNTH / S&P DNTH unavailable / 3.09% |
LoseDNTH / S&P DNTH unavailable / 4.83% |
LoseDNTH / S&P DNTH unavailable / 17.74% |
| 2017-Q10/3 |
LoseDNTH / S&P DNTH unavailable / 6.07% |
LoseDNTH / S&P DNTH unavailable / 3.67% |
LoseDNTH / S&P DNTH unavailable / 13.32% |
| 2016-Q40/3 |
LoseDNTH / S&P DNTH unavailable / 3.82% |
LoseDNTH / S&P DNTH unavailable / 2.09% |
LoseDNTH / S&P DNTH unavailable / 7.05% |
| 2016-Q30/3 |
LoseDNTH / S&P DNTH unavailable / 3.85% |
LoseDNTH / S&P DNTH unavailable / 0.20% |
LoseDNTH / S&P DNTH unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DNTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 373.23% | 20.78% |
| Annualized return | 373.23% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DNTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 6.76% | 83.14% |
| Annualized return | 1.32% | 12.86% |
10Y · 2018-06-21 to 2026-08-27
| Metric | DNTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -51.99% | 319.30% |
| Annualized return | -7.07% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |